Literature DB >> 1185105

Inhibition of lymphocyte mitogenesis by immobilized antigen-antibody complexes.

J L Ryan, R D Arbeit, H B Dickler, P A Henkart.   

Abstract

Mouse spleen cells, cultured on surfaces coated with antigen-antibody complexes, are inhibited from responding to the B-cell mitogens, lipopolysaccharide, lipid A, Pneumococcal polysaccharide SIII, and poly I:C. The response to the T-cell mitogen, concanavalin A, is also substantially inhibited by immobilized antigen-antibody complexes, but specific inhibition of the response to phytohemagglutinin is minimal. Control experiments showed that immobilized complexes prepared from IgG F(ab')2 fragments and IgA antibodies (both of which fail to bind to Fc receptors when complexed to antigen) did not show significant inhibitory activity when compared with the inhibition observed with complexes prepared from whole IgG. Suspensions of antigen-antibody complexes prepared from the same antigen and intact IgG antibody did not inhibit mitogenesis. None of the mitogens used could be demonstrated to compete with the binding of aggregated immunoglobulin to the B-cell Fc receptor. It appears that the interaction of Fc receptor-bearing lymphocytes and/or macrophages with immobilized complexes prevents lymphocyte activation by mitogens. It is suggested that the mechanism(s) involved may be relevant to antibody feedback control of the humoral immune response.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185105      PMCID: PMC2189949          DOI: 10.1084/jem.142.4.814

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Direct triggering of B lymphocytes by insolubilized antigen.

Authors:  M Feldmann; M F Greaves; D C Parker; M B Rittenberg
Journal:  Eur J Immunol       Date:  1974-09       Impact factor: 5.532

2.  Transfer of antigenic macromolecules from macrophages to lymphocytes. I. Autoradiographic and quantitative study of ( 14 C)endotoxin and ( 125 I)haemocyanin transfer.

Authors:  C Bona; A Anteunis; R Robineaux; A Astesano
Journal:  Immunology       Date:  1972-12       Impact factor: 7.397

3.  In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis.

Authors:  A Coutinho; G Möller; J Anderson; W W Bullock
Journal:  Eur J Immunol       Date:  1973-05       Impact factor: 5.532

4.  Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes.

Authors:  G Möller
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

5.  Inhibition of mitogenic stimulation of mouse lymphocytes by anti-mouse immunoglobulin antibodies. I. Mode of action.

Authors:  J Andersson; W W Bullock; F Melchers
Journal:  Eur J Immunol       Date:  1974-11       Impact factor: 5.532

6.  Properties of antibodies cytophilic for macrophages.

Authors:  A Berken; B Benacerraf
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

Review 7.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

8.  Purification of antibodies with immunoadsorbents prepared using bromoacetyl cellulose.

Authors:  J B Robbins; J Haimovich; M Sela
Journal:  Immunochemistry       Date:  1967-01

9.  Interaction of aggregated -globulin with B lymphocytes.

Authors:  H B Dickler; H G Kunkel
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Receptors for aggregated IgG on mouse lymphocytes: their presence on thymocytes, thymus-derived, and bone marrow-derived lymphocytes.

Authors:  C L Anderson; H M Grey
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  24 in total

1.  Aberrant secondary antibody responses to sheep erythrocytes in rabbits with experimental syphilis.

Authors:  R E Baughn; D M Musher
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Immunoregulation by covalent antigen-antibody complexes. II. Suppression of a T-cell independent anti-hapten response.

Authors:  J P Tite; R B Taylor
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

3.  Selective response of lymphocytes from Treponema pallidum-infected rabbits to mitogens and Treponema reiteri.

Authors:  C S Pavia; J B Baseman; J D Folds
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

4.  IgE Fc receptor positive T and B lymphocytes in patients with the hyper IgE syndrome.

Authors:  L F Thompson; H L Spiegelberg; R H Buckley
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

5.  IgG aggregates of different sizes stimulate or suppress Ig secretion by human lymphocytes in vitro.

Authors:  C Wiesenhutter; D W Knutson; D S Musgrave; R F Ashman
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

6.  The modulation of specific and non-specific cell-mediated immunity in baboons (Papio anubis) infected with Schistosoma mansoni.

Authors:  B J Cottrell; R F Sturrock
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

7.  Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.

Authors:  J R Kateley; S J Bazzell
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

8.  Failure to block lymphocyte Fc receptor with anti-B lymphocyte sera (anti-DRW) in man.

Authors:  J P Soulillou; M A Peyrat
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

9.  Lateral diffusion of surface immunoglobulin, Thy-1 antigen, and a lipid probe in lymphocyte plasma membranes.

Authors:  P Dragsten; P Henkart; R Blumenthal; J Weinstein; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

10.  Bovine milk IgG, but not serum IgG, inhibits pokeweed mitogen-induced antibody secretion by human peripheral blood mononuclear cells.

Authors:  A Kulczycki; G S Nash; M J Bertovich; H D Burack; R P MacDermott
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.